price
NASDAQ · ATOS
Atossa Therapeutics, Inc.
Healthcare · Biotechnology
$2.30
Up+$0.13 (+5.99%)
Updated Nov 3, 2026, 4:41 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 116.87M
- P/E ratio
- -4.07
- Dividend yield
- 0.00%
- 52-week range
- $1.70 – $14.85
- Volume
- 66.3K
- Avg. volume
- 872.57K
Price performance · ATOS
ATOS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
ATOS closed at $2.30 after 21 trading sessions, down 6.12% for the selected period.
- Last close
- $2.30
- Period change
- -6.12%
- Period low
- $2.17
- Period high
- $2.91
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $2.21 | $2.40 | $2.205 | $2.30 | 66.3K |
| Oct 30, 2026 | $2.25 | $2.43 | $2.14 | $2.17 | 32.9K |
| Oct 29, 2026 | $2.35 | $2.375 | $2.22 | $2.23 | 68.01K |
| Oct 28, 2026 | $2.38 | $2.425 | $2.36 | $2.37 | 29.46K |
| Oct 27, 2026 | $2.44 | $2.628 | $2.37 | $2.38 | 24.83K |
| Oct 26, 2026 | $2.58 | $2.58 | $2.40 | $2.45 | 35.08K |
| Oct 23, 2026 | $2.74 | $2.85 | $2.60 | $2.60 | 77.02K |
| Oct 22, 2026 | $2.49 | $2.77 | $2.46 | $2.72 | 90.66K |
| Oct 21, 2026 | $2.53 | $2.585 | $2.38 | $2.53 | 189.63K |
| Oct 20, 2026 | $2.54 | $2.67 | $2.51 | $2.54 | 36.76K |
| Oct 19, 2026 | $2.66 | $2.76 | $2.51 | $2.56 | 80.52K |
| Oct 16, 2026 | $2.59 | $2.95 | $2.51 | $2.91 | 104.63K |
| Oct 15, 2026 | $2.78 | $3.12 | $2.53 | $2.65 | 227.03K |
| Oct 14, 2026 | $2.52 | $2.81 | $2.4501 | $2.78 | 238.71K |
| Oct 13, 2026 | $2.35 | $2.60 | $2.30 | $2.56 | 71.41K |
| Oct 12, 2026 | $2.44 | $2.53 | $2.335 | $2.3887 | 81.42K |
| Oct 9, 2026 | $2.45 | $2.74 | $2.12 | $2.44 | 265.61K |
| Oct 8, 2026 | $2.46 | $2.478 | $2.385 | $2.42 | 101.01K |
| Oct 7, 2026 | $2.41 | $2.49 | $2.41 | $2.46 | 19.07K |
| Oct 6, 2026 | $2.46 | $2.54 | $2.43 | $2.45 | 54.63K |
| Oct 5, 2026 | $2.38 | $2.4999 | $2.341 | $2.45 | 53.32K |
Latest ATOS news
The latest Smart Investors Daily articles mentioning ATOS.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…